ANAPTYSBIO, INC. Active Patents
16 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-01-30: Application 18007361; Invention METHOD OF TREATING ICHTHYOSIS IN A SUBJECT BY ADMINISTERING AN ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) BINDING AGENT; Applicant AnaptysBio, Inc.; Status Patented Case.
- 2021-08-26: Application 17412737; Invention ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R); Applicant AnaptysBio, Inc.; Status Patented Case.
- 2020-10-15: Application 17071046; Invention METHOD OF TREATING AUTOIMMUNE DISEASE WITH ANTIBODIES AGAINST IL-33; Applicant AnaptysBio, Inc.; Status Patented Case.
- 2019-11-18: Application 16686373; Invention METHOD OF TREATING PUSTULAR PSORIASIS WITH ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R); Applicant AnaptysBio, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-30 | 18007361 | METHOD OF TREATING ICHTHYOSIS IN A SUBJECT BY ADMINISTERING AN ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) BINDING AGENT | AnaptysBio, Inc. | Patented Case | 2026-08-25 | 12715924 | US20230272092A1 | Amy Paller Emma Guttman Irina Khanskaya Rupal Kalapanda Marco Londei | United States United States United States United States United States | LANDSMAN, ROBERT S |
| 2021-08-26 | 17412737 | ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R) | AnaptysBio, Inc. | Patented Case | 2025-08-19 | 12391761 | US20210388095A1 | Peter BOWERS Andrew John MCKNIGHT David J. KING Marco LONDEI | United States United States United States United States | MCCOLLUM, ANDREA K |
| 2020-10-15 | 17071046 | METHOD OF TREATING AUTOIMMUNE DISEASE WITH ANTIBODIES AGAINST IL-33 | AnaptysBio, Inc. | Patented Case | 2024-06-04 | 11999783 | US20210040198A1 | Robert A. Horlick David J. King Andrew John McKnight | United States United States United States | JIANG, DONG |
| 2019-11-18 | 16686373 | METHOD OF TREATING PUSTULAR PSORIASIS WITH ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R) | AnaptysBio, Inc. | Patented Case | 2021-09-28 | 11130814 | US20200087408A1 | Peter BOWERS Andrew John MCKNIGHT David J. KING Marco LONDEI | United States United States United States United States | MCCOLLUM, ANDREA K |
| 2019-10-17 | 16655939 | ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN 3 (TIM-3) | AnaptysBio, Inc. | Patented Case | 2022-06-07 | 11352427 | US20200148770A1 | Marilyn KEHRY David J. KING Jean DA SILVA CORREIA | United States United States United States | NATARAJAN, MEERA |
| 2018-07-23 | 16042476 | METHOD OF TREATING INFLAMMATORY DISORDER WITH ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33) | AnaptysBio, Inc. | Patented Case | 2020-11-17 | 10836820 | US20180346562A1 | Robert A. Horlick David J. King Andrew John McKnight | United States United States United States | JIANG, DONG |
| 2017-10-16 | 15567045 | ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R) | AnaptysBio, Inc. | Patented Case | 2020-01-07 | 10526410 | US20180094065A1 | Peter BOWERS Andrew John MCKNIGHT David J. KING Marco LONDEI | United States United States United States United States | MCCOLLUM, ANDREA K |
| 2017-10-05 | 15726287 | ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1) | AnaptysBio, Inc. | Patented Case | 2020-08-11 | 10738117 | US20180051082A1 | David J. King Marilyn Kehry | United States United States | ROARK, JESSICA HOPE |
| 2017-10-02 | 15563924 | ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN 3 (TIM-3) | AnaptysBio, Inc. | Patented Case | 2019-12-17 | 10508149 | US20180127500A1 | Marilyn KEHRY David J. KING Jean DA SILVA CORREIA | United States United States United States | NATARAJAN, MEERA |
| 2017-08-02 | 15548405 | ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3) | AnaptysBio, Inc. | Patented Case | 2020-11-17 | 10836824 | US20180127496A1 | Helen Toni JUN Marilyn KEHRY Peter BOWERS David J. KING | United States United States United States United States | BELYAVSKYI, MICHAIL A |
| 2015-11-02 | 14888557 | ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1) | ANAPTYSBIO, INC. | Patented Case | 2017-11-14 | 9815897 | US20160075783A1 | David J. King Marilyn Kehry | United States United States | ROARK, JESSICA HOPE |
| 2014-12-31 | 14587479 | ANTIBODIES DIRECTED AGAINST NERVE GROWTH FACTOR (NGF) | ANAPTYSBIO, INC. | Patented Case | 2018-04-24 | 9951126 | US20150118226A1 | David J. King Peter Bowers Robert A. Horlick Tamlyn Yee Neben | United States United States United States United States | HAYES, ROBERT CLINTON |
| 2014-02-14 | 14181096 | METHODS OF GENERATING LIBRARIES AND USES THEREOF | ANAPTYSBIO, INC. | Patented Case | 2016-02-16 | 9260533 | US20140170705A1 | Peter M. BOWERS Andrew B. CUBITT Robert A. HORLICK | United States United States United States | BOESEN, CHRISTIAN C |
| 2013-10-11 | 14052451 | METHODS OF GENERATING LIBRARIES AND USES THEREOF | ANAPTYSBIO, INC. | Patented Case | 2017-05-02 | 9637556 | US20140094392A1 | Peter M. BOWERS Andrew B. CUBITT Robert A. HORLICK | United States United States United States | BOESEN, CHRISTIAN C |
| 2013-08-21 | 13972524 | HUMANIZED ANTIBODIES DIRECTED AGAINST COMPLEMENT PROTEIN C5 | ANAPTYSBIO, INC. | Patented Case | 2015-09-15 | 9133269 | US20140056878A1 | Audrey MCCONNELL Peter M. BOWERS David J. KING | United States United States United States | GAMBEL, PHILLIP |
| 2012-10-24 | 13659308 | ANTIBODIES DIRECTED AGAINST NERVE GROWTH FACTOR (NGF) | ANAPTYSBIO, INC. | Patented Case | 2015-01-06 | 8926978 | US20130101601A1 | David J. King Peter Bowers Robert A. Horlick Tamlyn Yee Neben | United States United States United States United States | HAYES, ROBERT CLINTON |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |